Effect of CYP3A5 genotype on the extent of CYP3A inhibition by verapamil.

被引：3
|
作者：
Wang, Y [1 ]
Jin, Y [1 ]
Hilligoss, JK [1 ]
Ho, H [1 ]
Hamman, MA [1 ]
Hu, Z [1 ]
Gorski, JC [1 ]
Hall, SD [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.11.014
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P3 / P3
页数：1
相关论文
共 50 条
  • [1] Differential inhibition of CYP3A4 and CYP3A5 by verapamil.
    Wang, Y
    Jones, DR
    Hall, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P16 - P16
  • [2] Influence of CYP3A5 genotype on the extent of CYP3A inhibition in healthy African-Americans
    Isoherranen, Nina
    Paine, Mary F.
    Givens, Raymond C.
    Ludington, Shana S.
    Hawke, Roy L.
    Pusek, Susan N.
    Dees, E. Claire
    Blough, David
    Iwanaga, Kazunori
    Watkins, Paul B.
    Thummel, Kenneth E.
    DRUG METABOLISM REVIEWS, 2006, 38 : 89 - 89
  • [3] Effect of CYP3A5 genotype on the relationship between hepatic CYP3A activity and CYP3A4 and CYP3A5 mRNA expression
    Kolwankar, D
    Ho, H
    Ethell, B
    Vuppalanchi, R
    Marri, SR
    Wrighton, SA
    Jones, DR
    Hall, SD
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
  • [4] The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates
    Burk, Oliver
    Schwab, Matthias
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (12) : 1097 - 1098
  • [5] The limited impact of CYP3A5 genotype for the pharmacokinetics of CYP3A substrates
    Oliver Burk
    Matthias Schwab
    European Journal of Clinical Pharmacology, 2007, 63 : 1097 - 1098
  • [6] Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians
    E Gebeyehu
    E Engidawork
    A Bijnsdorp
    A Aminy
    U Diczfalusy
    E Aklillu
    The Pharmacogenomics Journal, 2011, 11 : 130 - 137
  • [7] Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians
    Gebeyehu, E.
    Engidawork, E.
    Bijnsdorp, A.
    Aminy, A.
    Diczfalusy, U.
    Aklillu, E.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (02): : 130 - 137
  • [8] The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans
    Roberts, Patrick J.
    Rollins, Kristan D.
    Kashuba, Angela D. M.
    Paine, Mary F.
    Nelsen, Andrew C.
    Williams, Eric E.
    Moran, Cassandra
    Lamba, Jatinder K.
    Schuetz, Erin G.
    Hawke, Roy L.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (08) : 1465 - 1469
  • [9] CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults
    Givens, RC
    Lin, YS
    Dowling, ALS
    Thummel, KE
    Lamba, JK
    Schuetz, EG
    Stewart, PW
    Watkins, PB
    JOURNAL OF APPLIED PHYSIOLOGY, 2003, 95 (03) : 1297 - 1300
  • [10] The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: An in vitro-in vivo evaluation
    Isoherranen, Nina
    Ludington, Shana R.
    Givens, Raymond C.
    Lamba, Jatinder K.
    Pusek, Susan N.
    Dees, E. Claire
    Blough, David K.
    Iwanaga, Kazunori
    Hawke, Roy L.
    Schuetz, Erin G.
    Watkins, Paul B.
    Thummel, Kenneth E.
    Paine, Mary F.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (01) : 146 - 154
12345